Skip to Main Content

Following a vote by the Maryland House of Delegates, the state now has all the pieces in place to proceed with plans for a so-called ‘Prescription Drug Affordability Board,’ a controversial tactic for controlling the rising cost of medicines.

The House voted 95-to-38 to override a veto issued last year by Gov. Larry Hogan, who objected to the board, which is designed to function like rate-setting boards that regulate what public utilities can charge residents. Last month, the Senate also overrode the veto, which Hogan issued over concerns the move would raise taxes and fees at a time when the Covid-19 pandemic had already hurt citizens.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!